03370nam 2200637Ia 450 991079149380332120200520144314.00-19-934900-21-282-76325-397866127632500-19-970788-X(CKB)2560000000016328(EBL)584585(OCoLC)667231115(SSID)ssj0000424194(PQKBManifestationID)12164644(PQKBTitleCode)TC0000424194(PQKBWorkID)10471138(PQKB)11731995(StDuBDS)EDZ0000173009(MiAaPQ)EBC584585(Au-PeEL)EBL584585(CaPaEBR)ebr10416906(CaONFJC)MIL276325(PPN)161875564(EXLCZ)99256000000001632820100216d2010 uy 0engur|n|---|||||txtccrNon-dopamine lesions in Parkinson's disease[electronic resource] /edited by Glenda M. Halliday, Roger A. Barker, Dominic B. RoweNew York Oxford University Press20101 online resource (337 p.)Description based upon print version of record.0-19-537108-9 Includes bibliographical references and index.Contents; Contributors; Chapter 1: Lesions Associated with the Classic Triad of Parkinsonian Motor Features; Chapter 2: Lesions Associated with Motor Speech; Chapter 3: Lesions Associated with Eye Movements; Chapter 4: Olfactory Dysfunction in Parkinson's Disease and Related Disorders; Chapter 5: Lesions Associated with Autonomic Dysfunction A: Swallowing Disorders and Drooling; Chapter 6: Lesions Associated with Pain and Sensory Abnormalities; Chapter 7: Lesions Associated with Sleep Disturbances; Chapter 8: Lesions Associated with Depression and ApathyChapter 9: Lesions Associated with Dyskinesias and the Dopamine Dysregulation SyndromeChapter 10: Lesions Associated with Visual Hallucinations and Psychoses; Chapter 11: Lesions Associated with Cognitive Impairment and Dementia; Chapter 12: Systemic Manifestations of Parkinson's Disease; IndexParkinson's disease becomes apparent only after substantial loss (>60%) of the dopamine neurons in the substantia nigra. By this time there has already been widespread neural inclusion formation in the peripheral and central nervous system of patients with the disease, although this has only been recognized more recently. Degeneration in these widespread regions of the peripheral and central nervous system is now known to impact on disease symptoms, progression and treatment over time. This book aims to provide a comprehensive review of these non-dopamine lesions in Parkinson's disease by asseParkinson's diseasePathophysiologyBrainDiseasesParkinson's diseasePathophysiology.BrainDiseases.616.8/33Halliday Glenda M1567537Barker Roger A.1961-1567538Rowe Dominic B1567539MiAaPQMiAaPQMiAaPQBOOK9910791493803321Non-dopamine lesions in Parkinson's disease3838990UNINA